参考文献/References:
[1]Caso JR,Balanza-Martinez V,Palomo T,et al.The Microbiota and Gut-Brain Axis:Contributions to the Immunopathogenesis of Schizophrenia[J].Curr Pharm Des,2016,22(40):6122-6133.
[2]Rosenblat JD,Cha DS,Mansur RB,et al.Inflamedmoods:A review of the interactions between inflammation and mood disorders[J].Prog Neuropsychopharmacol Biol Psychiatry,2014,17(53):23-34.
[3]JA Romijn,EP Corssmit,LM Havekes,et al.Gut-brain axis[J].Curr Opin Clin Nutr Metab Care,2008,11(4):518-521.
[4]Bravo JA,Forsythe P,Chew MV,et al.Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve[J].Proc Natl Acad Sci USA,2011,108(38):16050-16055.
[5]Douglas-Escobar,Elliott M.E,Neu J.Effect of intestinal microbial ecology on the developing brain[J].JAMA Pediatr,2013,167(4):374-379.
[6]Penders J.Factors influencing the composition of the intestinal microbiota in early infancy[J].Pediatrics,2006,118(2):511-521.
[7]RD Heijtz,S Wang,F Anuar,et al.Normal gut microbiota modulates brain development and behavior[J].Proc Natl Acad Sci USA,2011,108(7):3047-3052.
[8]N Sudo,Y Chida,Y Aiba,et al.Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice[J].J Physiol,2004,558(1):263-275.
[9]Forsythe P,Bienenstock J.Immunomodulation by commensal and probiotic bacteria[J].Immunol Invest,2010,39(4-5):429-448.
[10]Erny D,Hrabe de Angelis,Prinz M.Communicating systems in the body:howmicrobiota and microglia cooperate[J].Immunology,2017,150(1):7-15.
[11]M Vétizou,JM Pitt,R Daillère,et al.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J].Science,2015,350(6264):1079-1084.
[12]Erny D,Hrabe de Angelis AL,Jaitin D,et al.Hostmicrobiota constantly control maturation and function of microglia in the CNS[J].Nat Neurosci,2015,18(7):965-977.
[13]Lichtenstein P,Yip BH,Bjork C,et al.Common genetic determinants of schizophrenia and bipolar disorder in Swedish families:a population-based study[J].Lancet,2009,373(9659):234-239.
[14]Song X,Fan X,Zhang J,et al.Elevated levels of adiponectin and other cytokines in drug naive,first episode schizophrenia patients with normal weight[J].Schizophr Res,2013,150(1):269-273.
[15]Miller BJ,Buckley P,Seabolt W,et al.Meta-analysis of cytokine alterations in schizophrenia:clinical status and antipsychotic effects[J].Biol Psychiatry,2011,70(7):663-671.
[16]Buscaino V.Patologia extraneurale della schizofrenia.Fegato, tubodigerente,sistemareticolo-endoteliale[J].Acta Neurol,1953(8):1-60.
[17]Whitehead WE,Palsson O,Jones KR.Systematic review of the comorbidity of irritable bowel syndromewith other disorders:What are the causes and implications[J].Gastroenterology,2002,122(4):1140-1156.
[18]Sanjay Gupta,David Kaplanb,Amar Bhandaryb,et al.The relationship between schizophrenia and irritable bowel syndrome (IBS)[J].Schizophrenia Research,1997,23(3):265-268.
[19]Dickerson F,Severance E,Yolken R.Themicrobiome,immunity,and schizophrenia and bipolar disorder[J].Brain Behav Immun,2017,62(4):46-52.
[20]Severance EG,Alaedini A,Yang S,et al.Gastrointestinal inflammation and associated immune activation in schizophrenia[J].Schizophr Res,2012,138(1):48-53.
[21]Severance EG,Gressitt KL,Stallings CR,et al.Candida albicans exposures,sex specificity and cognitive deficits in schizophrenia and bipolar disorder[J].NPJ Schizophr,2016(2):16018.
[22]Coyle JT.NMDA receptor and schizophrenia:a brief history[J].Schizophr Bull,2012,38(5):920-926.
[23]Nieto R,Kukuljan M,Silva H.BDNFand schizophrenia:from neurodevelopment to neuronal plasticity,learning,and memory[J].FrontPsychiatry,2013(4):45.
[24]Durany N,Michel T,Boissl KW,et al.Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses[J].Schizophr Res,2001,52(1-2):79-86.
[25]Weickert CS,Hyde TM,Lipska BK,et al.Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia[J].Mol Psychiatry,2003,8(6):592-610.
[26]Zhao C,Deng W,Gage FH.Mechanisms and functional implications of adult neurogenesis[J].Cell,2008,132(4):645-660.
[27]Moghaddam B,Javitt D.From revolution to evolution:the glutamate hypothesis of schizophrenia and its implication for treatment[J].Neuropsychopharmacology,2012,37(1):4-15.
[28]JB Pyndt,L Krych,TB Pedersen,et al.Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia[J].Physiology &Behavior,2015,141(1):32-39.
[29]Davey KJ,O'Mahony SM,Schellekens H,et al.Gender-dependent consequences of chronic olanzapine in the rat:effects on body weight,inflammatory,metabolic and microbiota parameters[J].Psychopharmacology(Berl),2012,221(1):155-169.
[30]Morgan AP,Crowley JJ,Nonneman RJ,et al.The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse[J].PLoS One,2014,9(12):115-225.
[31]Lu K,Mahbub R,FoxJG.Xenobiotics:Interaction with the Intestinal Microflora[J].ILAR J,2015,56(2):218-227.
[32]Schwarz E,Maukonen J,Hyytiainen T,et al.Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response[J].Schizophr Res,2017,22(4):30204-30209.
[33]Arseneault-Breard J,Rondeat I,Gilbert K,et al.Combination of Lactobacillus helveticus R0052 and Bifidobacteriumlongum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model[J].Br J Nutr,2012,107(12):1793-1799.
[34]Messaoudi M,Lalonde R,Biolle N,et al.Assessment of psychotropic-like properties of a probiotic formulation(Lactobacillus helveticus R0052 and Bifidobacteriumlongum R0175)in rats and human subjects[J].Br J Nutr,2011,105(5):755-764.
[35]Cryan JF,O'Mahony SM.The microbiome-gut-brain axis:from bowel to behavior[J].Neurogastroenterol Motil,2011,23(3):187-192.
[36]Kadooka Y,Sato M,Imaizumi K,et al.Regulation of abdominal adiposity by probiotics(Lactobacillus gasseri SBT2055)in adults with obese tendencies in a randomized controlled trial[J].Eur J ClinNutr,2010,64(6):636-643.
[37]Vieira SM,Pagovich OE,Kriegel MA.Diet,microbiota and autoimmune diseases[J].Lupus,2014,23(6):518-526.
[38]Kalaydjian AE,Eaton W,Cascella N,et al.The gluten connection:the association between schizophrenia and celiac disease[J].Acta Psychiatrica Scandinavica,2006,113(2):82-90.
[39]Dohan FC,Grasberger JC.Relapsed schizophrenics:earlier discharge from the hospital after cereal-free,milk-free diet[J].Am J Psychiatry,1973,130(6):685-688.
相似文献/References:
[1]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Journal of Medical Information,2018,31(02):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[2]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症
疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(02):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[3]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状
疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(02):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[4]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(02):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[5]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Journal of Medical Information,2018,31(02):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[6]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(02):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[7]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Journal of Medical Information,2018,31(02):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[8]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Journal of Medical Information,2018,31(02):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[9]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Journal of Medical Information,2018,31(02):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
[10]陈宽玉,孔 骞,黄玉桃.首发缓解期精神分裂症患者日常生活模式的调查[J].医学信息,2019,32(04):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]
CHEN Kuan-yu,KONG Qian,HUANG Yu-tao.Investigation on the Daily Life Pattern of Patients with Schizophrenia in the First Remission Period[J].Journal of Medical Information,2019,32(02):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]